AAAAAA

   
Results: 1-9 |
Results: 9
Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation
Authors: Xie, SH Wang, Y Liu, JX Sun, T Wilson, MB Smithgall, TE Arlinghaus, RB
Citation: Sh. Xie et al., Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation, ONCOGENE, 20(43), 2001, pp. 6188-6195
BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model
Authors: Lin, F Monaco, G Sun, T Liu, JX Lin, H Stephens, C Belmont, J Arlinghaus, RB
Citation: F. Lin et al., BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model, ONCOGENE, 20(15), 2001, pp. 1873-1881
Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death
Authors: Wang, Y Liu, JX Wu, Y Luo, WP Lin, SH Lin, H Hawk, N Sun, T Guo, JQ Estrov, Z Talpaz, M Champlin, R Arlinghaus, RB
Citation: Y. Wang et al., Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death, CANCER RES, 61(1), 2001, pp. 138-144
Expression of bcr-abl mRNA in individual chronic myelogenous leukaemia cells as determined by in situ amplification
Authors: Pachmann, K Zhao, SR Schenk, T Kantarjian, H El-Naggar, AK Siciliano, MJ Guo, JQ Arlinghaus, RB Andreeff, M
Citation: K. Pachmann et al., Expression of bcr-abl mRNA in individual chronic myelogenous leukaemia cells as determined by in situ amplification, BR J HAEM, 112(3), 2001, pp. 749-759
Chronic myelogenous leukemia blast cell proliferation is inhibited by peptides that disrupt Grb2-SoS complexes
Authors: Kardinal, C Konkol, B Lin, H Eulitz, M Schmidt, EK Estrov, Z Talpaz, M Arlinghaus, RB Feller, SM
Citation: C. Kardinal et al., Chronic myelogenous leukemia blast cell proliferation is inhibited by peptides that disrupt Grb2-SoS complexes, BLOOD, 98(6), 2001, pp. 1773-1781
Preparation and application of antibodies to phosphoamino acid sequences
Authors: Sun, T Campbell, M Gordon, W Arlinghaus, RB
Citation: T. Sun et al., Preparation and application of antibodies to phosphoamino acid sequences, BIOPOLYMERS, 60(1), 2001, pp. 61-75
Cell-penetrating SH3 domain blocker peptides inhibit proliferation of primary blast cells from CML patients
Authors: Kardinal, C Konkol, B Schulz, A Posern, G Lin, H Adermann, K Eulitz, M Estrov, Z Talpaz, M Arlinghaus, RB Feller, SM
Citation: C. Kardinal et al., Cell-penetrating SH3 domain blocker peptides inhibit proliferation of primary blast cells from CML patients, FASEB J, 14(11), 2000, pp. 1529-1538
Bcr: a negative regulator of the Bcr-Abl oncoprotein
Authors: Wu, Y Ma, GZ Lu, D Lin, F Xu, HJ Liu, JX Arlinghaus, RB
Citation: Y. Wu et al., Bcr: a negative regulator of the Bcr-Abl oncoprotein, ONCOGENE, 18(31), 1999, pp. 4416-4424
Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor alpha-dependent signaling pathway
Authors: Le, XF Groner, Y Kornblau, SM Gu, Y Hittelman, WN Levanon, D Mehta, K Arlinghaus, RB Chang, KS
Citation: Xf. Le et al., Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor alpha-dependent signaling pathway, J BIOL CHEM, 274(31), 1999, pp. 21651-21658
Risultati: 1-9 |